Arrhythmia and cardiomyopathy frequently accompany muscular dystrophy. In t
he last year, the cardiovascular consequences of muscular dystrophy gene mu
tations have been established through studies of murine models. These model
s have highlighted the potential role of primary defects in cardiac muscle
as well as those secondary cardiovascular outcomes that arise from severe m
uscle disease. This review focuses on three areas. Recent studies using mou
se models have shown that the dystrophin-associated proteins, the sarcoglyc
ans and alpha -dystrobrevin, are critical for both cardiac and skeletal mus
cle membrane function, yet may exert their roles by different molecular mec
hanisms. New findings have shown that cytoskeletal proteins at the nuclear
membrane, such as emerin and lamin AC, cause muscular dystrophy and cardiom
yopathy with cardiac conduction system disease. Finally, the mechanism of c
ardiac and muscle degeneration in myotonic dystrophy has been re-evaluated
through a series of studies using murine models. Implications for human the
rapy are considered in light Of these new findings. (C) 2001 Lippincott Wil
liams & Wilkins, Inc.